| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |